• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Emageon extends backlog, strikes credit deal

Article

Current contracts signed by PACS and IT developer Emageon have extended the company's backlog of orders to a figure in excess of $100 million. Emageon attributes much of its success to partnering with large integrated delivery networks (IDNs), including

Current contracts signed by PACS and IT developer Emageon have extended the company's backlog of orders to a figure in excess of $100 million. Emageon attributes much of its success to partnering with large integrated delivery networks (IDNs), including Kaiser Permanente, Sisters of Mercy, Sutter Health, Allina Hospitals and Clinics, and Aurora Health Care. To date, more than 70 acute care hospitals and imaging facilities have implemented Emageon products. The company, which expects to complete 30 additional hospital implementations this year, currently has a customer base of more than 250 sites. Supporting future growth is a new agreement with IBM that will allow Emageon customers to obtain IBM Global Financing, providing a single-source agreement for financing Emageon products and services.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.